vs
CDW Corporation（CDW）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
CDW Corporation的季度营收约是费森尤斯医疗的1.0倍（$5.5B vs $5.5B），CDW Corporation同比增速更快（6.3% vs -0.3%）
CDW公司是美国多品牌信息技术服务提供商，服务覆盖美国、英国、加拿大三国的商业、政府、教育、医疗领域，总部位于伊利诺伊州弗农希尔斯，位列《财富》500强，2023年全年净销售额达210亿美元。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
CDW vs FMS — 直观对比
营收规模更大
CDW
是对方的1.0倍
$5.5B
营收增速更快
CDW
高出6.6%
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $5.5B |
| 净利润 | — | $434.2M |
| 毛利率 | 22.8% | 27.4% |
| 营业利润率 | 7.8% | 11.7% |
| 净利率 | — | 7.9% |
| 营收同比 | 6.3% | -0.3% |
| 净利润同比 | — | 240.4% |
| 每股收益（稀释后） | $2.13 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDWFMS
| Q4 25 | $5.5B | $5.5B | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.0B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.2B | $5.5B | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $5.4B | — | ||
| Q1 24 | $4.9B | — |
净利润CDWFMS
| Q4 25 | — | $434.2M | ||
| Q3 25 | $291.0M | — | ||
| Q2 25 | $271.2M | — | ||
| Q1 25 | $224.9M | — | ||
| Q4 24 | — | $127.6M | ||
| Q3 24 | $316.4M | — | ||
| Q2 24 | $281.1M | — | ||
| Q1 24 | $216.1M | — |
毛利率CDWFMS
| Q4 25 | 22.8% | 27.4% | ||
| Q3 25 | 21.9% | — | ||
| Q2 25 | 20.8% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 22.3% | 25.0% | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 21.8% | — |
营业利润率CDWFMS
| Q4 25 | 7.8% | 11.7% | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.9% | 5.1% | ||
| Q3 24 | 8.7% | — | ||
| Q2 24 | 8.0% | — | ||
| Q1 24 | 6.7% | — |
净利率CDWFMS
| Q4 25 | — | 7.9% | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 4.4% | — |
每股收益（稀释后）CDWFMS
| Q4 25 | $2.13 | — | ||
| Q3 25 | $2.21 | — | ||
| Q2 25 | $2.05 | — | ||
| Q1 25 | $1.69 | — | ||
| Q4 24 | $1.97 | — | ||
| Q3 24 | $2.34 | — | ||
| Q2 24 | $2.07 | — | ||
| Q1 24 | $1.59 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $618.7M | $1.7B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.6B | $15.4B |
| 总资产 | $16.0B | $33.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDWFMS
| Q4 25 | $618.7M | $1.7B | ||
| Q3 25 | $452.9M | — | ||
| Q2 25 | $481.0M | — | ||
| Q1 25 | $688.1M | — | ||
| Q4 24 | $717.7M | $1.3B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $665.3M | — | ||
| Q1 24 | $803.8M | — |
股东权益CDWFMS
| Q4 25 | $2.6B | $15.4B | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $17.0B | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $2.1B | — |
总资产CDWFMS
| Q4 25 | $16.0B | $33.5B | ||
| Q3 25 | $15.2B | — | ||
| Q2 25 | $15.3B | — | ||
| Q1 25 | $15.0B | — | ||
| Q4 24 | $14.7B | $36.3B | ||
| Q3 24 | $14.4B | — | ||
| Q2 24 | $13.6B | — | ||
| Q1 24 | $13.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $433.8M | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $395.9M | — |
| 自由现金流率自由现金流/营收 | 7.2% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | 6.67× |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流CDWFMS
| Q4 25 | $433.8M | $2.9B | ||
| Q3 25 | $328.3M | — | ||
| Q2 25 | $155.9M | — | ||
| Q1 25 | $287.2M | — | ||
| Q4 24 | $345.3M | $2.6B | ||
| Q3 24 | $342.1M | — | ||
| Q2 24 | $149.9M | — | ||
| Q1 24 | $440.0M | — |
自由现金流CDWFMS
| Q4 25 | $395.9M | — | ||
| Q3 25 | $298.5M | — | ||
| Q2 25 | $133.4M | — | ||
| Q1 25 | $260.3M | — | ||
| Q4 24 | $316.7M | — | ||
| Q3 24 | $308.5M | — | ||
| Q2 24 | $119.0M | — | ||
| Q1 24 | $410.5M | — |
自由现金流率CDWFMS
| Q4 25 | 7.2% | — | ||
| Q3 25 | 5.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 8.4% | — |
资本支出强度CDWFMS
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.6% | — |
现金转化率CDWFMS
| Q4 25 | — | 6.67× | ||
| Q3 25 | 1.13× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 1.28× | — | ||
| Q4 24 | — | 20.20× | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 2.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
